Tracking miR-17-5p Levels following Expression of Seven Reported Target mRNAs

被引:4
|
作者
Du, Kevin Y. [1 ]
Qadir, Javeria [1 ]
Yang, Burton B. [1 ,2 ]
Yee, Albert J. [1 ]
Yang, Weining [1 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
基金
加拿大健康研究院;
关键词
microRNA; non-coding RNA; miR-17-5p; 3 '-UTR; Argonaute; 2; RNA-induced silencing complex; cancer; HEPATOCELLULAR-CARCINOMA; MATURE MIR-17-5P; MICRORNAS; CANCER; BETA;
D O I
10.3390/cancers14112585
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As the most prominent member of the miR-17-92 cluster, miR-17-5p is well associated with tumorigenesis and cancer progression. It can exert both oncogenic and tumor-suppressive functions by inducing translational repression and/or mRNA decay. The complexity of the tissue-specific expression of the targeted transcripts seems to contribute to the differential functions of miR-17-5p in different types of cancers. In this study, we selected 12 reported miR-17-5p targeting genes with mRNA levels unaffected by miR-17-5p expression and analyzed their expression in 31 organ tissues in transgenic mice by real-time PCR. Surprisingly, miR-17-5p expressing transgenic mice showed a positive correlation in these tissues between miR-17-5p expression levels and the selected miR-17-5p targeted transcripts; with high expression of the miRNA in organs with high selected miRNA-targeted mRNA levels. In cancer cell lines, overexpression of 7 reported miR-17-5p targeted genes' 3'-UTRs promoted miR-17-5p expression; meanwhile, transfection of 3'-UTRs with mutations had no significant effect. Moreover, an increase in AGO2 mRNA was associated with 3-UTR expression as confirmed by real-time PCR. Hence, miR-17-5p regulation by these target genes might be an alternative mechanism to maintain miR-17-5p expression at tissue-specific levels.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
    Li, Ye
    Liang, Min
    Zhang, Yunhui
    Yuan, Bing
    Gao, Wenchao
    Shi, Zhizhou
    Bai, Jie
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Circulating miR-17-5p as a potential biomarker for diagnosis and prognosis in osteosarcoma
    Zhu, Hongxuan
    Liao, Qiande
    Yin, Ke
    Zhong, Da
    Wang, Chenggong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3409 - 3416
  • [33] Attenuation of circulating miR-17-5p, miR-20b-5p, and miR-106a-5p in low-risk prostate cancer patients following proton therapy
    Velasquez, Johnny
    Bryant, Curtis
    Mendenhall, Nancy
    Ricks-Santi, Luisel
    CANCER RESEARCH, 2024, 84 (06)
  • [34] High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
    Stoen, Maria Jenvin
    Andersen, S.
    Rakaee, M.
    Pedersen, M. I.
    Ingebriktsen, L. M.
    Bremnes, R. M.
    Donnem, T.
    Lombardi, A. P. G.
    Kilvaer, T. K.
    Busund, L. T.
    Richardsen, E.
    SCIENTIFIC REPORTS, 2021, 11 (01) : 13864
  • [35] Effects of miR-17-5p in Human Hepatocellular Carcinoma Cells by Modulating STAT3 Expression
    Zhang, N.
    Zhang, M.
    Song, H.
    Shen, Z.
    PANCREAS, 2018, 47 (05) : 531 - 531
  • [36] High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
    Maria Jenvin Stoen
    S. Andersen
    M. Rakaee
    M. I. Pedersen
    L. M. Ingebriktsen
    R. M. Bremnes
    T. Donnem
    A. P. G. Lombardi
    T. K. Kilvaer
    L. T. Busund
    E. Richardsen
    Scientific Reports, 11
  • [37] miR-34a, miR-29c and miR-17-5p expression in chronic lymphocytic leukemia patients is dependent on p53 functionality
    Mraz, Marek
    Kotaskova, Jana
    Malinova, Karla
    Pavlova, Sarka
    Tichy, Boris
    Malcikova, Jitka
    Trbusek, Martin
    Mayer, Jiri
    Pospisilova, Sarka
    CANCER RESEARCH, 2009, 69
  • [38] Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population
    Jin, Tianbo
    Wu, Xiaohong
    Yang, Hua
    Liu, Ming
    He, Yongjun
    He, Xue
    Shi, Xugang
    Wang, Fengjiao
    Du, Shuli
    Ma, Yajuan
    Bao, Shan
    Yuan, Dongya
    ONCOTARGET, 2016, 7 (47) : 76647 - 76655
  • [39] miR-17-5p Regulates Heterotopic Ossification by Targeting ANKH in Ankylosing Spondylitis
    Qin, Xiong
    Zhu, Bo
    Jiang, Tongmeng
    Tan, Jiachang
    Wu, Zhenjie
    Yuan, Zhenchao
    Zheng, Li
    Zhao, Jinmin
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 18 : 696 - 707
  • [40] miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells
    Hai-jiao Yan
    Wen-song Liu
    Wen-hui Sun
    Jun Wu
    Mei Ji
    Qi Wang
    Xiao Zheng
    Jing-ting Jiang
    Chang-ping Wu
    Digestive Diseases and Sciences, 2012, 57 : 3160 - 3167